Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention (PRISM)
Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence
About this trial
This is an interventional treatment trial for Polysubstance Addiction focused on measuring Substance-Related Disorders, Opioid-Related Disorders, Polysubstance Use, Mental disorders
Eligibility Criteria
Inclusion Criteria: Patient participants in the RCT must be 18 or older; receive OUD treatment as part of the telemedicine program; and exhibit polysubstance use within the past three-months (i.e., use of one or more non-prescribed substances (excluding opioids and/or tobacco) by urine toxicology or self-report. Exclusion Criteria: Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation Inability to understand the study and provide informed consent in English Positive pregnancy status at enrollment
Sites / Locations
- University of Maryland Baltimore (UMD Drug Treatment Center)
- University of Maryland, College Park
- Caroline County Behavioral HealthRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Peer-Delivered Behavioral Activation ("Peer Activate")
Treatment As Usual
Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention and reduce polysubstance use.
Participants in the TAU group will receive enhanced treatment as usual, defined as MTU services as usual enhanced with additional community referrals and follow-ups on those referrals, in addition to regular meetings with an addiction medicine physician and PRS on the MTU. Standard PRS contact typically includes connection to local resources and general peer support as needed.